HOOKIPA Pharma Inc banner

HOOKIPA Pharma Inc
OTC:HOOK

Watchlist Manager
HOOKIPA Pharma Inc Logo
HOOKIPA Pharma Inc
OTC:HOOK
Watchlist
Price: 0.9801 USD 9.39%
Market Cap: $12.1m

Wall St Price Targets

HOOK Price Targets Summary
HOOKIPA Pharma Inc

There are no price targets for HOOK.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
HOOKIPA Pharma Inc Competitors:
Price Targets
SMCP
SMCP SA
36% Upside
ULTA
Ulta Beauty Inc
24% Upside
STRO
Sutro Biopharma Inc
129% Upside
BRI
Britania PCL
4% Upside
NWSA
News Corp
23% Upside
SSRM
SSR Mining Inc
32% Upside
CALM
Cal-Maine Foods Inc
9% Upside
BTBT
Bit Digital Inc
236% Upside

Revenue
Forecast

34% / Year
Past Growth
-39% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
34% / Year
Past Growth
-39% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 6 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 3 years is -39%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HOOK's stock price target?
Not Available

HOOK does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for HOOKIPA Pharma Inc?
Projected CAGR
-39%

Over the last 6 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 3 years is -39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett